Mylan Sells Entire 5.64% Biocon Stake In Open Market Deal

15 July 2026

Biocon Ltd.

Mylan Inc (non-prom) sold 9.19Cr sh (5.64%) in Biocon via open mkt; before 9.19Cr, after nil.

Recent Events

Biocon Secures Japan Marketing Approval For Pegfilgrastim Biosimilar With Sandoz

Biocon Launches Yesafili Aflibercept Biosimilar in United States

Biocon Launches Yesafili Aflibercept Biosimilar Commercially In United States

Get features of